The goals of psoriasis treatment are to gain initial and rapid control of the disease; to decrease plaque lesions and percentage of body surface area involved, to achieve long-term remission; and to minimize adverse events.
Topical treatment for mild psoriasis includes topical corticosteroids, calcipotriene, tazarotene, topical tars, anthralin and keratolytics, and immunomodulators (pimecrolimus, tacrolimus). The treatment of moderate to severe psoriasis includes systemic therapies such as methotrexate, acitretin, cyclosporine, hydroxurea and biologicals. Topical treatment can be effective using combination, rotational or sequential regimens for patients with more severe disease. Details below . . .
Psoriasis treatment options included
• Topical treatments such as skin lotions, ointments, creams, and shampoos.
• Pills or injections that affect the body’s immune response, not just the skin.
• Phototherapy which uses light to treat psoriasis.
TOPICAL TREATMENTS (applied direct to the skin)
Most of the time, psoriasis is treated with medications that are placed directly on the skin or scalp. This may include:
• Cortisone creams and ointments
• Creams or ointments that contain coal tar or anthralin
• Creams to remove the scaling (usually salicylic acid or lactic acid)
• Dandruff shampoos (over-the-counter or prescription)
• Prescription medicines containing vitamin D or vitamin A (retinoids)
SYSTEMIC TREATMENTS (medication circulates throughout the body)
When psoriasis is very severe, practitioners will likely recommend medicines that suppress the immune system’s faulty response. These medicines include methotrexate or cyclosporine. Retinoids such as acitretin can also be used.
Newer drugs called biologics are used when other treatments do not work. Biologics for the treatment of psoriasis include:
• Adalimumab (Humira)
• Alefacept (Amevive)
• Etanercept (Enbrel)
• Infliximab (Remicade)
Topical corticosteroids (steroid creams) are often first line treatment for the management of psoriasis. However, the ongoing use of topical corticosteroid often generates additional skin damage (adverse events) for psoriasis patients such as epidermal atrophy, degeneration of the dermal structure and collagen deterioration. Additionally, topical corticosteroids can inhibit the skin’s ability to fight against bacterial and fungal infections. The link below this post (bottom right) provides an overview of corticosteroid – steroid cream skin damage.
Maállo is a novel post steroid therapeutic skin cream for use after topical corticosteroid medication. As a daily maintenance therapeutic Maállo suppresses the stimulus of psoriasis and supports the structure and function of the skin to reduce the dependency on topical corticosteroids. To learn more about Maállo Cream click here.
Kátha Soma therapeutics are formulated to help people living with cancer, chronic disease or slow cell renewal due to aging, minimize their sign & symptoms, achieve daily comfort and maintain quality of life. DISCLAIMER: Kátha Soma does not provide medical advice, diagnosis or treatment. The information provided is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition. www.Katha-Soma.com
Chronic diseases can not be cured, however they can be effectively managed.